Oseltamivir resistance during treatment of influenza A (H5N1) infection
about
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsAurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesInfluenza virus antigenic variation, host antibody production and new approach to control epidemicsSystematic review of influenza resistance to the neuraminidase inhibitorsCross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particleHeterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cellsLive, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsPathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humansResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsNeuraminidase inhibitors for preventing and treating influenza in healthy adultsPandemic potential of a strain of influenza A (H1N1): early findingsAntiviral drugs for viruses other than human immunodeficiency virusInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesSurvival of influenza virus on banknotes.Current and future antiviral therapy of severe seasonal and avian influenzaInefficient transmission of H5N1 influenza viruses in a ferret contact modelPandemic influenza: risk of multiple introductions and the need to prepare for them.Modeling human influenza infection in the laboratoryClinical Implications of Antiviral Resistance in InfluenzaStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesH5N1 vaccines in humansEffect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsProtective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infectionBroad-Spectrum Drugs Against Viral AgentsConserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B virusesStructural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesChanges in the hemagglutinin of H5N1 viruses during human infection – Influence on receptor bindingSynthesis, structure and inhibitory activity of a stereoisomer of oseltamivir carboxylateRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirReverse Genetics Approaches for the Development of Influenza VaccinesFatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceNanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionInfluenza viruses: breaking all the rulesA novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cellsAntiviral resistance and the control of pandemic influenzaA randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combinationNeuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread
P2860
Q21142658-79AEB7FD-1F5F-4605-9E80-5E4C632FC7EAQ21142689-EB554C34-6973-406B-9DDB-FCFE5AD18444Q21245119-3DBC3922-79BA-416F-8450-464857AC5E6EQ21261835-08E02701-BFED-491C-9485-0E1534B91589Q21562299-12AAB8E8-F879-4EA8-9905-2A44D7ED1854Q21562507-9E0A3DE2-8441-442A-B62E-CF1CC8D35D89Q21563426-1FD5EB1A-6A8D-46A0-A6CC-F097C7D38B82Q22255463-A2B6B7AE-D825-4843-8B23-8E3F1F914729Q22305941-42AF4500-2030-486E-A560-C556BBB67A57Q24240097-90EFD94B-8E87-450E-A51A-2DB7B3971187Q24244898-B5A69D7B-8C03-45F9-A1A8-6FBFAFDC7150Q24286924-B77D6F34-AFD1-4C49-BA3D-F03093358676Q24635330-BB8C903A-B492-471F-BB1E-64BAF649BFF1Q24645944-E820B0C6-C426-4B76-8AF2-6BDBD1AFA747Q24649949-BBCCF6F5-7367-493E-972E-D2DF457444D4Q24650616-72192D4D-777E-4DAD-BB18-FACA95D2B7FCQ24656164-E52426AF-E3C6-42A9-A04C-FCD765BA3616Q24684249-813C9411-6B08-4014-8A12-D570F35AA4F2Q25255931-EAE8B7FF-320B-411E-80B9-5F9FFF14BCC6Q26781842-8BF07FFA-6A9D-456A-8E10-DCDC912585E1Q26782746-43F79A8D-06F4-43CF-ABE5-E2008B8C9668Q26823492-80706180-88B2-49C1-A1C7-A8360397F8C9Q27000896-21862E53-BC24-4EAD-AE64-E5DAFE266777Q27314689-154A0AC0-80BB-43AE-ACC4-C8CB4C790F40Q27324824-F00BBBC4-ECF5-4BB5-97EB-3D4FB4EDF438Q27487859-A9046DD0-6CFD-4FF2-B6E3-1B748C57D19BQ27644686-D286C585-6BB4-47CC-84F5-0E979E6FC1FAQ27663966-1D0D80D8-9172-4E26-A60A-21DCCBD1A217Q27679989-B022569E-EDF8-4C9A-BDF1-9FBD968D87ECQ27688897-A1AF29D4-E262-4654-8DCC-217A5424C1DDQ28066861-B96678AA-8533-4AE0-81FA-F751DCD31F32Q28076140-2AEB3E02-FE72-438A-9B60-608AAEECA19EQ28262914-7FFB015F-690F-4785-88E4-47044C75AE5DQ28282405-121CE3DB-D32E-4D8D-84F3-D83904A9BFA5Q28308105-8B1D1986-122A-4A0C-B5E7-11C0311E0730Q28386965-E33C09FA-E784-49BA-AED9-7340DF2A99B8Q28390286-EB3809E7-04BA-40E0-9382-EE54FC0E226CQ28469119-622BB17A-7093-4CA4-AE54-FD208E9E2D71Q28471710-EC1125CD-AEB4-460E-9BD5-A37FD294415BQ28471814-28956A34-FDD6-4078-A4F3-E4BCBF8E40B6
P2860
Oseltamivir resistance during treatment of influenza A (H5N1) infection
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@ast
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@en
type
label
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@ast
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@en
prefLabel
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@ast
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@en
P2093
P50
P3181
P356
P1476
Oseltamivir resistance during treatment of influenza A (H5N1) infection
@en
P2093
Huu Khanh Truong
Menno D de Jong
Minh Hien Vo
Quang Ha Do
Tan Thanh Tran
Tinh Hien Tran
Tu Qui Phan
Van Cam Bach
Vinh Chau Nguyen
P304
P3181
P356
10.1056/NEJMOA054512
P407
P577
2005-12-01T00:00:00Z